bpc-157 gut health benefits evidence clinical safety NBC News bpc-157 oral effectiveness human studies

the compound's evidence base is limited to preclinical in vitro and animal (largely rodent) studies of IGF-1 receptor activation, muscle-cell signaling, and tissue repair, with human safety and efficacy data for this specific analog effectively absent

Preclinical research in animal models provides robust evidence for BPC-157s capacity to accelerate healing of damaged tendons, ligaments, muscle, and bone, while also protecting against gastrointestinal and neural injury

PMID 2137911 Subcutaneous injection-site pharmacokinetics FDA review

10.1016/j.vph.2018.02.010 76 VukojevicJ.VrdoljakB.MalekinusicD.SiroglavicM.MilavicM.KolencD.et al (2020)